AN ACT INCREASING THE RATE OF THE CREDIT REFUND VALUE FOR CERTAIN EXPENDITURES BY BIOTECHNOLOGY COMPANIES.
To increase the rate of the credit refund value for research and experimental expenditures or research and development expenses of biotechnology companies.
Introduced by:
Commerce Committee| New today | 2-4 days old | 5 days & older |
| Text of Bill | |
| CE Joint Favorable Change of Reference [doc] | |
| Raised Bill [doc] |
| Committee Actions | |
| CE Joint Fav. Rpt | |
| CE Vote Tally Sheet (Joint Favorable Change of Reference) |
Co-sponsors for Amendment LCO:
Bill History
| Date | Action Taken | ||
|---|---|---|---|
| 3/25/2024 | Favorable Change of Reference, House to Committee on Finance, Revenue and Bonding | ||
| 3/25/2024 | Favorable Change of Reference, Senate to Committee on Finance, Revenue and Bonding | ||
| 3/25/2024 | (LCO) | Reported Out of Legislative Commissioners' Office | |
| 3/22/2024 | (LCO) | Filed with Legislative Commissioners' Office | |
| 3/21/2024 | (CE) | Joint Favorable Change of Reference Finance, Revenue and Bonding | |
| 3/8/2024 | Public Hearing 03/14 | ||
| 3/7/2024 | Referred to Joint Committee on Commerce |
Co-sponsors of SB-379
Sen. Tony Hwang, 28th Dist.
NOTE: Please direct all inquiries regarding the status of bills to the Office of the House Clerk and/or Senate Clerks' Office.
